SAC Member Wins Prestigious Award Dr. Ramesh Panchagnula, Ph.D., member of the Global Alliance for TB Drug Development’s Scientific Advisory
NEW YORK, NY – OCT 20, 2004 – The Global Alliance for TB Drug Development (TB Alliance), a public-private partnership
New Donor Brings Support for Innovative Drug Development to $50 million The United States Agency for International Development (USAID), the
Each year, the international TB community gathers together at the UNION World Conference on Lung Health to discuss TB and
TB Alliance Adds New Member to Research & Development Team The Global Alliance for TB Drug Development (TB Alliance), a
The latest in a series of announcements this year, Lupin Limited, Inc., an Indian pharmaceutical and a TB Alliance Stakeholder,
Dr. Christopher Lipinski, member of the TB Alliance Scientific Advisory Committee and a retired Senior Research Fellow at Pfizer Global
TB Alliance Adds New Member to Research & Development Team The Global Alliance for TB Drug Development (TB Alliance), a
“Public-private partnerships have adopted business models that exploit the venture capital approach to investment in new product R&D…The commitment of
